MEthylphenidate in ADHD - Addiction(s) comorbidity: benefit of adding a cognitive remediation program to improve short- and medium-term therapeutic response
Age over 18;
Diagnosis of ADHD confirmed by DIVA-5 interview following a specialized ADHD-addiction(s) consultation;
Indication for MPH treatment according to European recommendations (J. J. S. Kooij et al., 2019) and absence of contraindications (particularly cardiological);
Presence of at least one comorbid addictive disorder (SUD and/or BA);
Presence of disorders of the higher functions or difficulties in reading or writing the French language making it impossible to collect data;
Pregnant or breast-feeding woman;
Person deprived of liberty;
Person under compulsory psychiatric care;
Nantes University Hospital
Lead sponsor